iHuman Inc.

FRC's fair value estimate for iHuman Inc., and the rating behind it. IH last traded at $1.18, 3.4× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for iHuman Inc.. Starting points for iHuman Inc.: P/E 3.4, EPS $2.34, beta 0.13 — an Education & Training Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for iHuman Inc.. iHuman Inc. paid $0.09 per share over the last year — a 7.2% yield at the current $1.18 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for iHuman Inc.. Trailing twelve-month EPS for iHuman Inc. stands at $2.34. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for iHuman Inc.. iHuman Inc. has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

iHuman Inc. valued side by side against its closest peers. iHuman Inc. is measured against Education & Training Services peers within the Consumer Defensive sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold iHuman Inc., and how their positions are changing. At a $12.1M market value, institutional positions materially move iHuman Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by iHuman Inc. executives and directors. Shares of iHuman Inc. have traded between $1.47 and $3.60 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming iHuman Inc.. iHuman Inc. is a $12.1M Consumer Defensive company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming iHuman Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for iHuman Inc.. Coverage tracks iHuman Inc. within Education & Training Services (Consumer Defensive). Press releases and market coverage, newest first.